FI6164U1 - Ondansetronmuotoja - Google Patents

Ondansetronmuotoja

Info

Publication number
FI6164U1
FI6164U1 FI20030093U FIU20030093U FI6164U1 FI 6164 U1 FI6164 U1 FI 6164U1 FI 20030093 U FI20030093 U FI 20030093U FI U20030093 U FIU20030093 U FI U20030093U FI 6164 U1 FI6164 U1 FI 6164U1
Authority
FI
Finland
Prior art keywords
ondansetronformer
Prior art date
Application number
FI20030093U
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Raymond Josef Hubertu Westheim
Dalen Frans Van
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of FIU20030093U0 publication Critical patent/FIU20030093U0/fi
Application granted granted Critical
Publication of FI6164U1 publication Critical patent/FI6164U1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20030093U 2003-01-09 2003-03-06 Ondansetronmuotoja FI6164U1 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43878003P 2003-01-09 2003-01-09

Publications (2)

Publication Number Publication Date
FIU20030093U0 FIU20030093U0 (fi) 2003-03-06
FI6164U1 true FI6164U1 (fi) 2004-03-15

Family

ID=23741979

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20030093U FI6164U1 (fi) 2003-01-09 2003-03-06 Ondansetronmuotoja

Country Status (9)

Country Link
US (1) US20040198794A1 (nl)
EP (1) EP1581519A1 (nl)
AU (2) AU2003222765A1 (nl)
DK (1) DK200300114U3 (nl)
FI (1) FI6164U1 (nl)
FR (1) FR2849852A1 (nl)
GB (1) GB2398566A (nl)
NL (1) NL1022893C2 (nl)
WO (1) WO2004063189A1 (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2238001B1 (es) 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
CA2565854A1 (en) 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
EP1828141A4 (en) * 2004-10-26 2009-04-01 Ipca Lab Ltd STAINING METHOD FOR PREPARING THE ANTIEMETIC 1,2,3,9-TETRAHYDRO-9-METHYL-3 - [(2-METHYL) -1H-IMIDAZOLE-1-YL) METHYL] -4H-CARBAZOLE-4-ON

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
NL190373C (nl) * 1984-01-25 1994-02-01 Glaxo Group Ltd Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat.
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
EP1339707A2 (en) * 2000-10-30 2003-09-03 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
IL156835A0 (en) * 2001-01-11 2004-02-08 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
DE20320528U1 (de) * 2002-04-30 2004-09-16 Teva Pharmaceuticals Usa, Inc. Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten

Also Published As

Publication number Publication date
DK200300114U3 (da) 2004-04-23
FR2849852A1 (fr) 2004-07-16
NL1022893C2 (nl) 2004-07-13
GB0306944D0 (en) 2003-04-30
GB2398566A (en) 2004-08-25
AU2003203580A1 (en) 2004-07-29
AU2003222765A1 (en) 2004-08-10
WO2004063189A1 (en) 2004-07-29
FIU20030093U0 (fi) 2003-03-06
EP1581519A1 (en) 2005-10-05
US20040198794A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
ATE363383T1 (de) Schlingenware
DE502004011133D1 (de) Uteils
DE502004011955D1 (de) Doppelkuppllungsgetriebe
DE502004001683D1 (de) Kabelführung
DE502004009566D1 (de) Raftfahrzeug
AT502792A5 (de) Düsenanpressvorrichtung
DE502004007911D1 (de) Wischblatt
DE112004000620D2 (de) Struktoguss
DE502004000672D1 (de) Pigmentpreparationen
DE502004008321D1 (de) Bandaufwickelverfahren
DE502004011362D1 (de) Ahrzeugsitzes
DE502004001524D1 (de) Hydrolager
ATA662003A (de) Trink-mundstück
ATE446959T1 (de) Chromenonindole
DE502004001629D1 (de) Bremsenprüfstand
DE502004003122D1 (de) Hydrolager
DE502004009786D1 (de) Rdnung
DE502004008889D1 (de) Schaltgabel
DE502004000518D1 (de) Mitgängergabelhubwagen
DE10394329D2 (de) Mäanderstent
DE10355350A8 (de) Elektromodul
DE112004002227D2 (de) Nietverarbeitungsgerät
DE502004007959D1 (de) Prolinylarylacetamide
DE10329218B4 (de) Hotflue
DE112004001561D2 (de) Getriebene-Antreibseinheit

Legal Events

Date Code Title Description
MAU Utility model expired